Local excision and external beam radiotherapy in early rectal cancer

Int J Radiat Oncol Biol Phys. 1996 Jul 1;35(4):759-64. doi: 10.1016/0360-3016(96)00133-2.

Abstract

Purpose: To assess the local control and survival of local excision and postoperative radiation in patients with early stage rectal cancer.

Methods and materials: From 1980 to 1992, 21 patients with clinical stage T1-2NxM0 adenocarcinoma of the middle and lower rectum were treated with transanal excision and postoperative external beam radiotherapy (44.6 Gy). The pathologic T stages were: 9 T1 (43%) and 12 T2 (57%). One patient had unassessable resection margins. The median follow-up was 54 months (range: 18-128 months).

Results: The actuarial local recurrence-free survival at 5 years was 85.2%, and the overall survival at 5 years was 80.6%. One patient developed a local recurrence and distant metastases at 22 months, and two patients had local recurrence at 11 and 15 months, respectively; both had abdomino-perineal resection (APR) and one remained free of disease 16 months after APR. The incidence of Grade 3 diarrhea was 5%. Sphincter function was good to excellent in the 18 patients with local control. No patients developed clinical evidence of pelvic lymph node recurrence.

Conclusion: These results are similar to other published series and suggest that this approach is feasible in selected patients with T1-2NxM0 rectal cancer and results in good long-term control of the disease.

MeSH terms

  • Adenocarcinoma / mortality
  • Adenocarcinoma / therapy*
  • Combined Modality Therapy
  • Humans
  • Neoplasm Recurrence, Local
  • Radiotherapy Dosage
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / therapy*